Table 1.
Baseline characteristics of study patients.
| Variable | Control | Insulin Resistance | Sepsis | p-Value |
|---|---|---|---|---|
| Group (% male) | 18 (33) | 32 (69) | 16 (56) | 0.053 * |
| Age [a] | 56 ± 11 | 65 ± 7 | 70 ± 9 | <0.001 |
| BMI [kg/m2] | 24.9 ± 4.1 | 28.4 ± 4.4 | 29.1 ± 4.4 | 0.007 |
| HOMA-IR [AU] | 1.5 ± 1.0 | 4.1 ± 5.1 | 4.3 ± 4.8 | 0.080 |
| Fasting Glucose [mmol/L] | 5.2 ± 0.4 | 7.6 ± 2.5 | 5.8 ± 1.8 | <0.001 |
| HbA1c [%] | 5.5 ± 0.4 | 7.0 ± 1.7 | 5.9 ± 1.1 | <0.001 |
| HDL [mmol/L] | 1.5 ± 0.46 | 1.13 ± 0.3 | 0.47 ± 0.88 | <0.001 |
| LDL [mmol/L] | 3.25 ± 0.90 | 3.41 ± 1.15 | 0.74 ± 0.57 | <0.001 |
| TC [mmol/L] | 5.06 ± 0.98 | 5.09 ± 1.27 | 2.35 ± 0.85 | <0.001 |
| TAG [mmol/L] | 1.48 ± 1.09 | 2.13 ± 0.88 | 2.21 ± 1.01 | 0.003 |
| ALAT [mU/L] | 0.56 ± 0.17 | 0.64 ± 0.29 | 0.88 ± 0.73 | 0.695 |
| GGT [mU/L] | 0.90 ± 0.62 | 1.61 ± 2.56 | 2.71 ± 2.41 | 0.047 |
| CRP [mg/dL] | 3.8 ± 2.5 | 12.4 ± 32.3 | 221.2 ± 99.6 | <0.001 |
| Leukocytes [Gpt/mL] | 6.0 ± 1.5 | 7.1 ± 1.9 | 16.0 ± 6.1 | <0.001 |
| Platelets [Gpt/mL] | 236 ± 68 | 256 ± 71 | 330 ± 176 | 0.175 |
| Thromboplastine time [%] | 109 ± 11 | 101 ± 17 | 76 ± 10 | <0.001 |
| Creatinine [mmol/L] | 67 ± 11 | 89 ± 25 | 189 ± 116 | <0.001 |
| Lipid lowering drugs [%] | 0 | 16 | 6 | - |
* χ2 test.